Aug 28, 2025, 15:54
Bishal Gyawali: Inferior Control Arms in LMIC Oncology Trials in a New BMJ Oncology Editorial
Bishal Gyawali, Associate Professor at Queen’s University and Associate Editor of the Journal of the National Cancer Institute, shared a post on X:
”Our new editorial just published in BMJ Oncology led by Laure-Anne Teuwen, where we discuss the use of inferior control arm in cancer drug trials run in LMICs.”
Ian Davis, Professor of Medicine at Eastern Health Clinical School, Monash, and Director and Chair of ANZUP, shared the post on X with the following comment:
”Excellent editorial – I agree with every word.”
Title: Inferior control arms in oncology trials in LMICs: contextualised or compromised?
Authors: Laure-Anne Teuwen, Bishal Gyawali
You can read the Full Article on BMJ Oncology.
More posts featuring Bishal Gyawali.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 15:53
Aug 28, 2025, 15:48
Aug 28, 2025, 15:40
Aug 28, 2025, 15:28
Aug 28, 2025, 15:27
Aug 28, 2025, 15:15